Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide EGFR Mutation Test market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 10.4% during the forecast period.
This report presents the market size and development trends by detailing the EGFR Mutation Test market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the EGFR Mutation Test market will be shown in this report. In short, this report will comprehensively reveal the characteristics of EGFR Mutation Test industry and will help you to build a panoramic view of the industrial development.
EGFR Mutation Test Market, By Type:
DNA Sequencing
Kits
EGFR Mutation Test Market, By Application:
Cancer Hospitals
Clinical Research Institutes
Some of the leading players are as follows:
BioMerieux
Abbott
Genomic Health
Hologic
Agilent Technologies
Thermo Fisher Scientific
QIAGEN
Novartis
Illumina
Merck
Roche
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 EGFR Mutation Test Market: Technology Type Analysis
-
4.1 EGFR Mutation Test Technology Type Market Share Analysis, 2018 & 2026
-
4.2 EGFR Mutation Test Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 DNA Sequencing
4.3.2 Kits
5 EGFR Mutation Test Market: Product Analysis
-
5.1 EGFR Mutation Test Product Market Share Analysis, 2018 & 2026
-
5.2 EGFR Mutation Test Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 EGFR Mutation Test Market: Application Analysis
-
6.1 EGFR Mutation Test Application Market Share Analysis, 2018 & 2026
-
6.2 EGFR Mutation Test Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Cancer Hospitals
6.3.2 Clinical Research Institutes
7 EGFR Mutation Test Market: Regional Analysis
-
7.1 EGFR Mutation Test Regional Market Share Analysis, 2018 & 2026
-
7.2 EGFR Mutation Test Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 BioMerieux
9.1.1 BioMerieux Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Abbott
9.2.1 Abbott Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Genomic Health
9.3.1 Genomic Health Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Hologic
9.4.1 Hologic Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Agilent Technologies
9.5.1 Agilent Technologies Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Thermo Fisher Scientific
9.6.1 Thermo Fisher Scientific Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 QIAGEN
9.7.1 QIAGEN Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Novartis
9.8.1 Novartis Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Illumina
9.9.1 Illumina Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Merck
9.10.1 Merck Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 Roche
9.11.1 Roche Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
The List of Tables and Figures (Totals 76 Figures and 155 Tables)
Figure DNA Sequencing EGFR Mutation Test market, 2015 - 2026 (USD Million)
Figure Kits EGFR Mutation Test market, 2015 - 2026 (USD Million)
Figure Cancer Hospitals market, 2015 - 2026 (USD Million)
Figure Clinical Research Institutes market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America EGFR Mutation Test market, by country, 2015 - 2026 (USD Million)
-
Table North America EGFR Mutation Test market, by type, 2015 - 2026 (USD Million)
-
Table North America EGFR Mutation Test market, by product, 2015 - 2026 (USD Million)
-
Table North America EGFR Mutation Test market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. EGFR Mutation Test market, by type, 2015 - 2026 (USD Million)
-
Table U.S. EGFR Mutation Test market, by product, 2015 - 2026 (USD Million)
-
Table U.S. EGFR Mutation Test market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada EGFR Mutation Test market, by type, 2015 - 2026 (USD Million)
-
Table Canada EGFR Mutation Test market, by product, 2015 - 2026 (USD Million)
-
Table Canada EGFR Mutation Test market, by application, 2015 - 2026 (USD Million)
-
Table Europe EGFR Mutation Test market, by country, 2015 - 2026 (USD Million)
-
Table Europe EGFR Mutation Test market, by type, 2015 - 2026 (USD Million)
-
Table Europe EGFR Mutation Test market, by product, 2015 - 2026 (USD Million)
-
Table Europe EGFR Mutation Test market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. EGFR Mutation Test market, by type, 2015 - 2026 (USD Million)
-
Table U.K. EGFR Mutation Test market, by product, 2015 - 2026 (USD Million)
-
Table U.K. EGFR Mutation Test market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany EGFR Mutation Test market, by type, 2015 - 2026 (USD Million)
-
Table Germany EGFR Mutation Test market, by product, 2015 - 2026 (USD Million)
-
Table Germany EGFR Mutation Test market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France EGFR Mutation Test market, by type, 2015 - 2026 (USD Million)
-
Table France EGFR Mutation Test market, by product, 2015 - 2026 (USD Million)
-
Table France EGFR Mutation Test market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy EGFR Mutation Test market, by type, 2015 - 2026 (USD Million)
-
Table Italy EGFR Mutation Test market, by product, 2015 - 2026 (USD Million)
-
Table Italy EGFR Mutation Test market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain EGFR Mutation Test market, by type, 2015 - 2026 (USD Million)
-
Table Spain EGFR Mutation Test market, by product, 2015 - 2026 (USD Million)
-
Table Spain EGFR Mutation Test market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific EGFR Mutation Test market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific EGFR Mutation Test market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific EGFR Mutation Test market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific EGFR Mutation Test market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China EGFR Mutation Test market, by type, 2015 - 2026 (USD Million)
-
Table China EGFR Mutation Test market, by product, 2015 - 2026 (USD Million)
-
Table China EGFR Mutation Test market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan EGFR Mutation Test market, by type, 2015 - 2026 (USD Million)
-
Table Japan EGFR Mutation Test market, by product, 2015 - 2026 (USD Million)
-
Table Japan EGFR Mutation Test market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India EGFR Mutation Test market, by type, 2015 - 2026 (USD Million)
-
Table India EGFR Mutation Test market, by product, 2015 - 2026 (USD Million)
-
Table India EGFR Mutation Test market, by application, 2015 - 2026 (USD Million)
-
Table Latin America EGFR Mutation Test market, by country, 2015 - 2026 (USD Million)
-
Table Latin America EGFR Mutation Test market, by type, 2015 - 2026 (USD Million)
-
Table Latin America EGFR Mutation Test market, by product, 2015 - 2026 (USD Million)
-
Table Latin America EGFR Mutation Test market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil EGFR Mutation Test market, by type, 2015 - 2026 (USD Million)
-
Table Brazil EGFR Mutation Test market, by product, 2015 - 2026 (USD Million)
-
Table Brazil EGFR Mutation Test market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico EGFR Mutation Test market, by type, 2015 - 2026 (USD Million)
-
Table Mexico EGFR Mutation Test market, by product, 2015 - 2026 (USD Million)
-
Table Mexico EGFR Mutation Test market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina EGFR Mutation Test market, by type, 2015 - 2026 (USD Million)
-
Table Argentina EGFR Mutation Test market, by product, 2015 - 2026 (USD Million)
-
Table Argentina EGFR Mutation Test market, by application, 2015 - 2026 (USD Million)
-
Table MEA EGFR Mutation Test market, by country, 2015 - 2026 (USD Million)
-
Table MEA EGFR Mutation Test market, by type, 2015 - 2026 (USD Million)
-
Table MEA EGFR Mutation Test market, by product, 2015 - 2026 (USD Million)
-
Table MEA EGFR Mutation Test market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa EGFR Mutation Test market, by type, 2015 - 2026 (USD Million)
-
Table South Africa EGFR Mutation Test market, by product, 2015 - 2026 (USD Million)
-
Table South Africa EGFR Mutation Test market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria EGFR Mutation Test market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria EGFR Mutation Test market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria EGFR Mutation Test market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table BioMerieux Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Abbott Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Genomic Health Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Hologic Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Agilent Technologies Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Thermo Fisher Scientific Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table QIAGEN Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Novartis Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Illumina Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Merck Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Roche Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
